Bill

Bill > S603


MA S603

Relative to the care and treatment of patients with mitochondrial disease


summary

Introduced
01/22/2019
In Committee
01/22/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

For legislation relative to the care and treatment of patients with mitochondrial disease. Financial Services.

AI Summary

This bill proposes to amend various chapters of the General Laws to require coverage for the treatment of mitochondrial disease, including the use of specific vitamin and nutritional supplements such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1, and L-Carnitine. The bill applies to active and retired state employees, as well as individual and group insurance policies, hospital service plans, medical service agreements, and health maintenance contracts delivered or renewed within the Commonwealth of Massachusetts.

Committee Categories

Business and Industry

Sponsors (11)

Last Action

Accompanied a study order, see S2543 (on 02/18/2020)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...